AccuLine

📍 Petah-Tikva, Israel🗓 Founded 2022👥 7 employees💰 Last funded 2022
Medical Equipment Manufacturing🌐 acculine-medical.com
Website LinkedIn
AccuLine is a digital healthcare company, which was founded with the vision to saves the lives of millions of people worldwide, by preventing the next heart attack. AccuLine is developing CORA— a smart, accurate, and easy to use exam for the early detection of coronary artery disease. The clinically validated CORA deploys advanced ML-powered signal processing algorithms, analyzing two bio-signals the company discovered in the heart’s electrical activity, indicating the patient’s risk of having coronary artery disease. AccuLine has received a grant from the Israeli Innovation Authority and is a portfolio company of eHealth Ventures—founded by Maccabi Health Services, backed by Amgen, Medison Ventures, SCI (Shanghai Creation Investment), and partnered with Mayo Clinic.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
1
Frequently asked questions
Who invested in AccuLine?
AccuLine has 1 investors on record on gritt.io, including 1 early-stage backers.
When did AccuLine last raise funding?
The most recent investment in AccuLine recorded on gritt.io was in 2022.
When was AccuLine founded?
AccuLine was founded in 2022.
What industry is AccuLine in?
AccuLine operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is AccuLine based?
AccuLine is headquartered in Petah-Tikva, Israel.